Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2020-05-10 Regulatory Filings
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
ODC Manufacturing Permit Granted 2 pages 358.6KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 11 May 2020 regarding the granting of a Manufacture Permit by the Office of Drug Control to Little Green Pharma. It discusses operational plans and the significance of the permit for manufacturing cannabis extracts. The document is short (3914 characters), contains no financial statements or detailed financial data, and is primarily an announcement of a regulatory permit grant. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it does not mention any report being attached or published. The content is a regulatory announcement about a permit, which aligns best with the Regulatory Filings (RNS) category as a general regulatory announcement that does not fit other specific categories.
2020-05-10 English
Proposed issue of Securities - LGP 5 pages 28.6KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by Little Green Pharma Ltd. It details the nature of the securities (share rights), the number to be issued, the proposed issue date, conditions including shareholder approval, and other terms related to the placement. There is no financial statement or report content, but rather a formal notification of a capital raising event. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising or capital structure changes.
2020-05-07 English
Virtual Conference 2 pages 192.1KB
Investor Presentation Classification · 95% confidence The document is an ASX announcement dated 29 April 2020 about a live virtual conference presentation by the Managing Director of Little Green Pharma. It describes the event details, registration information, and mentions that a copy of the presentation will be lodged with the ASX prior to the event. The document does not contain any financial data, detailed report content, or results. It is essentially an announcement of an upcoming investor presentation event rather than the presentation itself or a financial report. The document length is short (3124 characters), and it fits the pattern of an announcement rather than a full report or transcript. Therefore, the most appropriate classification is Investor Presentation (IP) as it relates to a presentation for investors focusing on company updates and strategy.
2020-04-29 English
Quarterly Activities Report and Appendix 4C 10 pages 799.7KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'MARCH 2020 QUARTERLY ACTIVITIES REPORT AND APPENDIX 4C' and contains detailed operational and financial information for the quarter ended 31 March 2020. It includes sales data, patient and prescriber growth, export milestones, licensing updates, COVID-19 response measures, and a reconciliation of use of funds. The document also contains an Appendix 4C, which is a quarterly cash flow report required by the ASX Listing Rules. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive quarterly report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2020
2020-04-29 English
Investor Presentation 11 pages 647.1KB
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation April 2020' and contains detailed information about the company's business model, financial and operational metrics, sales agreements, corporate overview, and capital structure. It includes forward-looking statements, disclaimers, and is clearly designed to inform investors about the company's strategy, performance, and market position. There are no indications that this is a regulatory filing, earnings release, or annual/interim report. The length and content are consistent with a presentation format rather than a formal report or announcement. Therefore, the document fits the definition of an Investor Presentation (IP).
2020-04-29 English
First UK Shipment of Australian Medicinal Cannabis Oil 2 pages 209.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 15 April 2020 about the first export of Australian medicinal cannabis oil to the UK. It contains no financial statements, no detailed financial data, no regulatory certifications, or management discussions. It is a corporate announcement about a business milestone and market opportunity, not a report or filing of financial results or governance. The document length is 4301 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is a report publication announcement or a regulatory filing. The content fits best as a general regulatory announcement about business operations and market development, which falls under Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2020-04-14 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.